StockData
Heartflow, Inc. logo

Heartflow, Inc. (HTFL) stock

HTFLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30453% above fair value
$47.07+0.21 (+0.45%)

Close on Nov 17, 2026Market cap $4.09BP/E –Yield –

Heartflow r&d expenses

Research and development expenses are spending on new products and technology.

Heartflow's R&D Expenses for the twelve months ending Jun 30, 2026 was $83.84M, up 57.9% year over year. For fiscal 2025 it was $64.92M, up 49.2% from the year before.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$64.92M+49.2%
FY2024Dec 31, 2024$43.52M+21.4%
FY2023Dec 31, 2023$35.85M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$26.26M+74.7%
Q1 FY2026Mar 31, 2026$21.62M+55.3%
Q4 FY2025Dec 31, 2025$18.67M+52.0%
Q3 FY2025Sep 30, 2025$17.30M+45.8%
Q2 FY2025Jun 30, 2025$15.03M+51.3%
Q1 FY2025Mar 31, 2025$13.92M–
Q4 FY2024Dec 31, 2024$12.28M–
Q3 FY2024Sep 30, 2024$11.86M–
Q2 FY2024Jun 30, 2024$9.93M–

More Heartflow figures

See a number that looks wrong?